These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15024437

  • 1. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.
    Low DE, Pichichero ME, Schaad UB.
    Clin Pediatr (Phila); 2004 Mar; 43(2):135-51. PubMed ID: 15024437
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic implications of antibacterial resistance in community-acquired respiratory tract infections in children.
    Cunha BA.
    Infection; 2004 Apr; 32(2):98-108. PubMed ID: 15057574
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activity of the ketolide antibacterial telithromycin against typical community-acquired respiratory pathogens.
    Felmingham D, Zhanel G, Hoban D.
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():33-42. PubMed ID: 11566974
    [Abstract] [Full Text] [Related]

  • 9. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J.
    Int J Clin Pract; 2003 Sep; 57(6):519-29. PubMed ID: 12918892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of new antibacterial therapies in at-risk populations.
    Lorenz J.
    J Infect; 2002 Feb; 44 Suppl A():25-30. PubMed ID: 12150492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New developments in antibacterial choice for lower respiratory tract infections in elderly patients.
    Ferrara AM, Fietta AM.
    Drugs Aging; 2004 Feb; 21(3):167-86. PubMed ID: 14979735
    [Abstract] [Full Text] [Related]

  • 18. Elderly patients with community-acquired pneumonia: optimal treatment strategies.
    Thiem U, Heppner HJ, Pientka L.
    Drugs Aging; 2011 Jul 01; 28(7):519-37. PubMed ID: 21721597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cefditoren and community-acquired lower respiratory tract infections (corrected)].
    Barberán J, Mensa J.
    Rev Esp Quimioter; 2009 Sep 01; 22(3):144-50. PubMed ID: 19662548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.